baber/WOPTO huggingface dataset:
Patent AU-2016420618-A1 (AU)
Title: A Combined Heat and Power Plant and a Method for Improving the Burning Process in a Combined Heat and Power Plant
Inventor: TERHO ESA
IPC: C10J3/86
Filed: 2016-08-25
Abstract: The invention relates to a combined heat and power plant (10), comprising -a gasifier (11), for converting of carbonaceous material in to raw synthesis gas (21a), -a heat exchanger (12) arranged to reduce the temperature of the raw synthesis gas (21a) formed in the gasifier (11) by exchanging the heat of the raw synthesis gas (21a) in to heating medium to be used for heating and thereby forming cooled raw synthesis gas (21b), - a filtration unit (13) for cleaning the cooled raw synthesis (21b) gas to form refined synthesis gas (21c) suitable as a fuel for an internal combustion engine (14), -an internal combustion engine (14) wherein the refined synthesis gas (21c) is burnt to produce mechanical power, -ducts for connecting different parts of the plant (10) to each other, including a first raw gas duct (16) lead from the gasifier (11) to the heat exchanger (12), a second raw gas duct (17) lead from heat exchanger (12) to the filtration unit (13), a refined gas duct (18) lead from the filtration unit (13) to the to the internal combustion engine (14) and an exhaust gas duct to which the exhaust gas (23) of the internal combustion engine (14) is conducted, -a raw gas burner (20) arranged after the gasifier (11) to burn the raw synthesis gas (21a) formed in the gasifier (11) during the time when the refined synthesis gas (21c) is not utilized in the internal combustion engine (14). In the combined heat and power plant (10) according to the invention the a raw gas burner (20) is arranged to heat the heating medium of the heat exchanger (12). The invention relates also to a method for treating raw synthesis gas produced by a gasifier in and a combined heat and power plant.
Patent AU-2017202156-A1 (AU)
Title: Methods and compositions for delivery of nucleic acids
Inventor: HOPE MICHAEL J
IPC: A61K9/133
Filed: 2017-03-31
Abstract: METHODS AND COMPOSITIONS FOR DELIVERY OF NUCLEIC ACIDS Abstract: A lipid particle can include a plurality of cationic lipids, such as a first cationic lipid and a second cationic lipid. The first cationic lipid can be selected on the basis of a first property and the second cationic can be selected on the basis of a second property. The first and second properties are complementary. The attributes of the lipid particle can reflect the selected properties of the cationic lipids, and the complementary nature of those properties.
Patent AU-2017202500-A1 (AU)
Title: Compounds useful for treating cancer
Inventor: ROUX PIERRE
IPC: A61P43/00
Filed: 2017-04-18
Abstract: The present invention relates to compound (I) x W, - - U Rn R'n' z N Y T 5 wherein: z means a pyridazine, a pyrimidine or a pyrazine group, R independently represent a hydrogen atom, a halogen atom or a group chosen among a -CN group, a hydroxyl group, a -COOR 1 group, a (CI-C3)fluoroalkyl group, a (CI-C3)fluoroalkoxy group, a -NO 2 group, a -NR 1 R2 group, a (CI-C4)alkoxy group, a 10 phenoxy group and a (CI-C 3 )alkyl group, said alkyl being optionally mono-substituted by a hydroxyl group, n is 1, 2 or 3, n' is 1 or 2, R' is a hydrogen atom, a halogen atom or a group chosen among a (C1-C3)alkyl group, , a hydroxyl group, a -COOR 1 group, a -NO 2 group, a -NR1 R2 group, a morpholinyl 15 or a morpholino group, a N-methylpiperazinyl group, a (C1-C3)fluoroalkyl group, a (C1-C4)alkoxy group and a -CN group, Z is N or C, Y is N or C, X is N or C, W is N or C, T is N or C, U is N or C, for use as an agent for preventing, inhibiting or treating cancer. Some of said compounds are new and also form part of the invention.
Patent AU-2017203160-A1 (AU)
Title: Bcl-2-like protein 11 srm/mrm assay
Inventor: KRIZMAN DAVID B
IPC: G01N30/72
Filed: 2017-05-12
Abstract: Abstract Provided are methods for quantifying the Bcl-2-like protein 11 (BIM) protein directly in biological samples that have been fixed in formalin by the method of Selected Reaction Monitoring (SRM) mass spectrometry or Multiple Reaction Monitoring (MRM). Such biological samples are chemically preserved and fixed, including tissues or tissue culture cells that have been formalin fixed and or paraffin embedded. A fragmented peptide sample is prepared and quantitated by the method of SRM/MRM mass spectrometry by quantitating in the protein sample at least one or more of the peptides described. These peptides can be quantitated if they reside in a modified or an unmodified form. An example of a modified form of a BIM peptide is phosphorylation of a tyrosine, threonine, serine, and/or other amino acid residues within the peptide sequence.
Patent AU-2017210580-A1 (AU)
Title: Minimal surface area contact device for holding plaque to blood vessel wall
Inventor: SCHNEIDER PETER
IPC: A61F2/86
Filed: 2017-08-03
Abstract: A tack device for holding plaque against blood vessel walls in treating atherosclerotic occlusive disease is formed as a thin, annular band of durable, flexible material having a plurality of focal elevating elements on its outer annular periphery for holding loose plaque under a spring or other expansion force against a blood vessel wall. The focal elevating elements are designed to exert a holding force on a plaque position while minimizing the amount of material surface area in contact with the plaque or blood vessel wall and reducing the potential of friction with the intraluminal surface. This approach offers clinicians the ability to perform a minimally invasive post-angioplasty treatment and produce a stent-like result without using a stent.
Patent AU-2017213543-A1 (AU)
Title: Gaming machine feature
Inventor: JOHNSON STEPHEN
IPC: G07F17/32
Filed: 2017-08-11
Abstract: Abstract A method in a gaming system comprising an electronic game controller, the method comprising the steps of: determining whether a first prize awarding condition occurs during a play of a game by a player; awarding the player a first number of credits in response to the first awarding condition occurring; determining whether the player wants to wager a portion of the first number of credits in one of a plurality of selectable second games for an opportunity to be awarded a second number of credits, wherein the plurality of second games are each independent of the first game and wherein respective second numbers of credits associated with each of the plurality of second games are different to one another; if it is determined that the player wants to wager the portion of the first number of credits in one of the plurality of second games, determining whether a second prize awarding condition occurs during the play of the second game, wherein a probability of the second prize awarding condition occurring is based on a function of the portion of the first number of credits and the respective second number of credits. ..?2~ "2%, -.~ "''"'F IG .
Patent AU-2017219063-A1 (AU)
Title: Urea derivatives and uses thereof
Inventor: KIM JINSOO
IPC: C07D471/04
Filed: 2017-08-24
Abstract: Abstract The present invention provides novel compounds of any one of Formulae (I)-(II1), and pharmaceutical compositions thereof. Also provided are particles (e.g., nanoparticles) comprising compounds of Formula (I)-(III) and pharmaceutical compositions thereof that are mucus penetrating. The invention also provides methods and kits for using the inventive compounds, and pharmaceutical compositions thereof, for treating and/or preventing diseases associated with abnormal or pathological angiogenesis and/or aberrant signaling of a growth factor (e.g., vascular endothelial growth factor (VEGF)), such as proliferative diseases (e.g., cancers, benign neoplasms, inflammatory diseases, autoimmune diseases) and ocular diseases (e.g., macular degeneration. glaucoma,. diabetic retinopathy, retinoblastoma, edema. uveitis, dry eye, blepharitis, and post-surgical inflammation) in a subject in need thereof. Figure 1 10 20 30 40 2-theta (deg)
Patent AU-2017220728-A1 (AU)
Title: Veldoreotide with poor solubitliy in physiological conditions for use in the treatment of acromegaly, acromegaly cancer, SST-R5 expressing tumors, type 2 diabetes, hyperglycemia, and hormone-related tumors
Inventor: AFARGAN MICHAEL
IPC: A61K31/00
Filed: 2017-02-16
Abstract: The present invention provides compositions comprising water soluble peptides with poor solubility in isotonic solutions which exhibit enhanced bioavailability with reduced adverse effects including injection site reactions. Methods are also disclosed for using such compositions for the treatment of diseases including, but not limited to, cancer, type 2 diabetes, acromegaly, metabolic disorders, endocrine disorders, exocrine tumors, and hormone-related tumors. Methods to reduce adverse injection site reactions and improve bioavailability are also disclosed.
Patent AU-2017227554-A1 (AU)
Title: Perfusion balloon with external valve
Inventor: GOMES GARRETT
IPC: A61M25/10
Filed: 2017-02-28
Abstract: An apparatus (10) for performing a medical procedure and, in particular, an aortic valvuloplasty, in a vessel for transmitting a flow of fluid. The apparatus includes an inflatable perfusion balloon (12) including an internal passage for permitting the fluid flow in the vessel while the perfusion balloon is in an inflated condition, the balloon including a plurality of cells (12a) in a single cross section and a covering for at least partially covering (18) the cells. A valve (20) associated with the balloon controls the fluid flow within the passage, the valve being arranged external to the passage. The valve may form a tubular extension (18a) of the covering, or may be separate from the covering, and may comprise flaps (22, 30a). A spiral covering (28) may also form the valve.
Patent AU-2017238225-A1 (AU)
Title: System and method for assembling an erosion-preventing mat
Inventor: MOTZ JAMES G
IPC: E01F7/02
Filed: 2017-03-23
Abstract: A system for forming an erosion-preventing laminate mat having a layer of a first mat beneath a substantially flat, elongate sheet of tied block mat includes a movable frame having an upper surface shaped to pass beneath and support a segment of the tied block mat above the ground, the frame including a spindle suspended below the upper surface that retains a roll of the layer of the sheet material.
Patent AU-2017245307-A1 (AU)
Title: Methods of identification and diagnosis of lung diseases using classification systems and kits thereof
Inventor: STREEPER ROBERT T
IPC: G01N33/574
Filed: 2017-10-04
Abstract: The invention provides biomarkers and combinations of biomarkers useful in diagnosing lung diseases such as non-smail cell lung cancer or reactive airway disease. Measurements of these biomarkers are inputted into a classification system such as a support vector machine or AdaBoost to assist in determining the likelihood that an individual has a lung disease. Kits comprising agents for detecting the biomarkers and combination of biomarkers, as well as systems that assist in diagnosing lung diseases are also provided. FLUORESCENCE INTENSITY LEVEL IN THE NORMAL POPULATION Bionarker Average S.D. R.S.D. Biomarker Average S.D. R.S.D. Adiponectin 2259.55 1504.98 66.61 IL-17 37.60 13.52 35.95 Resistin 124.37 90.22 72.55 IL-la 95.36 185.32 194.33 PAl-I^ 335.10 371.63 110.90 IFN-y 23.30 9.28 39.81 SE-selectin 60.34 47.58 78.85 G-CSF 23.84 4.12 17.29 sVCAM-I 1753.31 513.04 29.26 GM-CSF 28.60 12.57 43.94 slCAM-1 3295.75 1574.35 47.77 TNF-u 43.52 15.71 36.10 MPO 592.73 1503.40 253.64 MCP-1 46.39 29.47 63.51 CRP 8384.00 6292.94 75.06 IL-12 (p40) 24.93 7.26 29.11 SAA 2202.71 4017.36 182.38 MIP-lu 41.04 27.61 67.27 SAP 2200.71 570.75 25.93 MIP-1p 21.28 9.86 46.35 Leptin' 2204.67 2771.37 125.70 VEGF 40.80 11.45 28.07 GLP-I 56.21 102.46 182.27 IL12 (p70) 7.66 36.69 479.00 Aimylin (Total) 142.47 339.44 238.25 IL-13 11.41 57.04 499.86 C-Peptide 4748.58 1971.09 41.51 MMP-2 155.73 439.49 282.21 Insulin 278.12 424.50 152.63 MMP-1 103.52 179.41 173.31 Sfas 58.81 148.38 252.31 MMP-3 6668.81 2442.77 36.63 sFSI 15.13 16.89 111.59 Eotaxin 196.78 208.46 105.94 MIF 52.08 112.39 215.81 Leptin2 3767.80 3885.08 103.11 IL-lp 23.71 9.52 40.16 IP-10 543.43 820.15 150.92 IL-2 12.26 44.02 358.99 MMP-9 1090.51 1599.16 146.64 IL-Ira 23.11 19.35 83.77 MMP-13 9.95 35.67 358.67 IL-4 114.39 72.33 63.23 PAI-1" 38.94 98.35 252.58 IL-5 18.37 18.35 99.90 I-TAC 30.16 154.83 513.40 IL-6 40.99 56.56 137.98 MMP-12 12.41 27.69 223.09 IL-7 15.82 6.6! 41.79 HGF 206.22 619.73 300.52 TGF-a 31.46 8.00 25.44 MMP-7 1004.07 577.62 57.53 Fractalkine 13.36 3.35 25.09 EGF 30.91 49.02 158.60 IL-8 239.47 629.22 262.76 sCD40 ligand 155.50 434.04 279.12 IL-10 13.06 3.63 27.82 MMP-8 70.26 318.85 453.80 IL-15 24.53 4.27 17.42 1
Patent AU-2017257864-A1 (AU)
Title: Lead-based alloy and related processes and products
Inventor: PRENGAMAN DAVID R
IPC: H01M4/57
Filed: 2017-04-26
Abstract: A lead-based alloy containing alloying additions of bismuth, antimony, arsenic, and tin is used for the production of doped leady oxides, lead-acid battery active materials, lead-acid battery electrodes, and lead-acid batteries.
Patent AU-2017258492-A1 (AU)
Title: Interferon beta antibodies and uses thereof
Inventor: GULLA STEFANO V
IPC: A61K39/00
Filed: 2017-04-28
Abstract: The invention relates to antibodies, or antigen-binding fragments thereof, that specifically binds to interferon beta (IFNp). Such antibodies, or antigen-binding fragments thereof, are are useful for various therapeutic or diagnostic purposes.
Patent AU-2017268710-A1 (AU)
Title: Arthrogenic alphavirus vaccine
Inventor: MAHALINGAM SURENDRAN
IPC: C07K19/00
Filed: 2017-05-25
Abstract: The invention relates to a vaccine comprising live attenuated recombinant alphavirus comprising mutated capsid protein. The invention also relates to a method of preventing a subject from contracting an alphaviral infection that would otherwise produce clinical signs of disease. In an embodiment the mutated capsid protein is Chikungunya virus (CHIKV) capsid protein having a mutated nucleolar localisation signal/sequence (NoLS), preferably the mutant NLS 101/95.
Patent AU-2017272960-A1 (AU)
Title: Decorative object, such as an item of jewellery, comprising a body and a decorative element reversibly attached to the body
Inventor: MANDON LAURENT
IPC: A44C15/00
Filed: 2017-05-29
Abstract: The invention proposes a decorative object, such as a jewellery item, comprising a body and a decorative element reversibly attached to the body in such a way that the decorative element can easily be changed. According to the invention, the decorative object comprises a reversible attachment system for attaching the decorative element to the body, comprising: • On the decorative element (200): o A first locking stud (210) onto which a rigid rod (211) is pivotably mounted; o A second locking stud (220) provided with a reversible locking means (221) for locking the rod (211) in the attachment position; • On the body: o A first locking opening intended to receive the first locking stud (210) of the decorative element; o A second locking opening intended to receive the second locking stud (220) of the decorative element; A bearing surface (230) being arranged, in the attachment position, between the two locking studs (210–220), and on which the rod (211) is intended to bear with force when it is locked in the attachment position by the reversible attachment means (221) of the second locking stud (220).
Patent AU-2017281543-A1 (AU)
Title: Production of carbon-based oxide and reduced carbon-based oxide on a large scale
Inventor: KOWAL MATTHEW
IPC: C01B32/00
Filed: 2017-06-23
Abstract: Provided herein are carbon-based oxide (CBO) materials and reduced carbon-based oxide (rCBO) materials, fabrication processes, and devices with improved performance and a high throughput. In some embodiments, the present disclosure provides materials and methods for synthesizing CBO and rCBO materials. Such methods avoid the shortcomings of current synthesizing methods to facilitate facile, high-throughput production of CBO and rCBO materials.
Patent AU-2017287706-A1 (AU)
Title: A hinge mechanism and a hinge assembly
Inventor: CLARK ANTHONY JOHN
IPC: E05F1/12
Filed: 2017-06-27
Abstract: A hinge mechanism comprising first and second members rotatable relative to one another about a hinge axis from a first to a second position; and a biasing arrangement operative to adopt an active mode to bias the first and second members into at least one relative position and operative to adopt an inactive mode where the biasing arrangement does not provide bias to the first or second members to undergo relative rotation, wherein the biasing arrangement remains in the inactive mode on relative rotation of the first and second members through a first selected angular displacement between the first position and the second position, and is in the active mode on relative rotation of the first and second members through a second selected angular displacement between the first position and the second position.
Patent AU-2017289698-A1 (AU)
Title: Distributed fibre optic sensing for in-train forces monitoring
Inventor: ESPREY CHRIS
IPC: B61L1/20
Filed: 2017-06-19
Abstract: This application relates to methods and apparatus for monitoring data obtained as a train (202) travels on along a rail track (201) to detect the occurrence and/or severity of any significant in-train forces, such as may be caused by heavy braking or excessive acceleration. The method involves taking a first data set corresponding to measurement signals from a plurality of channels of at least one fibre optic distributed acoustic sensor (202) having a sensing fibre (101) deployed to monitor at least part of the rail track. The first data set corresponds to measurement signals acquired as the train passes along the rail track. The method involves analysing the measurement signals to detect a first characteristic signature (402) which consists of a sequence of acoustic transients that appear to propagate rearwards along the train.
Patent AU-2017315312-A1 (AU)
Title: Declaring quasi co-location among multiple antenna ports
Inventor: ISLAM MUHAMMAD NAZMUL
IPC: H04L5/00
Filed: 2017-07-31
Abstract: Antenna ports on wireless devices may be QCL. QCL antenna ports may be useful in improving channel statistics related to the antenna ports. UEs and base stations may be able to determine candidate QCL ports, transmit information identifying the candidate QCL ports, and receive feedback indicating whether the candidate QCL ports are QCL at the receiving device such as a UE or a base station.
Patent AU-2017336537-A1 (AU)
Title: Harvested bale wrapping material sheets
Inventor: PORTER KENNETH L
IPC: A01F15/07
Filed: 2017-09-27
Abstract: In a continuous roll of wrapping material for crops such as cotton or hay, the individual wrapping segments are arranged so that a permanent adhesive is protected until the point when this adhesive is to be exposed for securing a wrapping segment to itself, encircling a subject bale located in and harvested from a field, wherein the contiguous wrapping segments separate from each other either at a point of weakness associated with perforations and the like, or as overlaid segments that slidably come apart.
Patent AU-2017362883-A1 (AU)
Title: Method and system for operating a hybrid power generation system
Inventor: GANIREDDY GOVARDHAN
IPC: H02S50/00
Filed: 2017-11-06
Abstract: A method and a system (111) for operating a hybrid power generation system (100) are presented, the hybrid power generation system (100) includes a wind power generation system (102), a wind power controller (104), a photo-voltaic (PV) power generation system, and a PV power controller (108). The method includes determining a hybrid-level power demand of the hybrid power generation system (100). The method further includes determining respective power demand set-points of the wind power generation system (102) and the PV power generation system (106) based at least in pail on the hybrid-level power demand. The method also includes communicating the power demand set-points of the wind power generation system (102) and the PV power generation system (106) respectively to at least one of the wind power controller (104) and the PV power controller (108). A farm (300) having a farm level control system (304) is also presented.
Patent AU-2017379407-A1 (AU)
Title: System and method for generating extended satellite ephemeris data
Inventor: GRANT ALEXANDER JAMES
IPC: G01S19/27
Filed: 2017-12-21
Abstract: A method and system for generating extended satellite ephemeris data for a satellite for use by a terminal apparatus is described. Historical orbital parameter data (e.g. from historical TLEs) are used to build a predictor for future values of the orbital parameters. The orbital parameter prediction model is then stored on the terminal apparatus (or an existing model can be updated), and at a desired epoch the pre-stored orbital parameter predictor is used to produce estimates of the orbital parameters for the satellite for that epoch (ie synthetic or predicted TLEs). These predicted orbital parameters (predicted TLE) are then used as input to a standard orbit predictor to produce an estimate of the satellite's location, for example to determine satellite pass times. This method allows generation satellite ephemeris data which is valid out to a year or more as compared to the normal validity of ephemeris data of a few hours or days.
Patent WO-2018129583-A1 (WO)
Title: Applicateur amélioré de compositions dermatologiques
Inventor: CAMPBELL CAMERON
IPC: A61M35/00
Filed: 2018-01-05
Abstract: L'invention concerne un applicateur actionné manuellement qui permet d'appliquer une composition sur la peau d'un être humain et qui est adapté à l'auto-application de compositions de bronzage artificiel ou d'éclaircissement de la peau. L'applicateur est configuré de sorte à être associé à la main de l'utilisateur (et peut être une mitaine ou un gant) et comprend une partie réservoir configurée de sorte à retenir un volume d'une composition dermatologique liquide, l'applicateur étant en outre configuré de sorte à distribuer de manière régulée une composition dermatologique liquide retenue sur une surface de la peau en contact avec celle-ci. La partie réservoir peut être configurée de sorte à retenir au moins environ 10 ml d'une composition dermatologique liquide. L'applicateur peut avoir une structure et/ou une composition qui inhibe ou empêche sensiblement une migration latérale d'une composition dermatologique sur l'applicateur.
Patent AU-2018201855-A1 (AU)
Title: Wireless access method and relevant device and system
Inventor: XU JIANHUA
IPC: H04B5/00
Filed: 2018-03-15
Abstract: The present invention provides a wireless access method and a related device and system, where the method includes: reading, by a terminal device, access point information stored in an external near field communication tag; and acquiring, by the 5 terminal device, one piece of target access point information according to the read access point information, and establishing, according to the target access point information, a wireless connection to an access point to which the target access point information belongs. Implementing the present invention can avoid operations of manually enabling access point search and manually entering a password by a user, so 10 that efficiency in accessing an access point can be effectively improved.
Patent AU-2018202954-A1 (AU)
Title: Compounds and their methods of use
Inventor: SAUNDERS JEFFREY O
IPC: A61P35/00
Filed: 2018-04-30
Abstract: Provided are compounds of formula (1), which can inhibit glutaminase. Pharmaceutical compositions comprising these compounds and uses as glutaminase inhibitors for treating cancers thereof are also provided.